Matches in Nanopublications for { ?s ?p "[First, a Finnish study observed that the NAT2 slow acetylator phenotype was associated with an increased risk of MM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- assertion description "[First, a Finnish study observed that the NAT2 slow acetylator phenotype was associated with an increased risk of MM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP254031.RAPGAt1wuyTuB-MmspAKs2wxN_84xq-vF2XEMnLuVs-oU130_assertion description "[First, a Finnish study observed that the NAT2 slow acetylator phenotype was associated with an increased risk of MM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP254031.RAPGAt1wuyTuB-MmspAKs2wxN_84xq-vF2XEMnLuVs-oU130_provenance.
- NP944547.RAdXHuX-_WmL8a3QdgzLEsOLX8wtw4D4NoGsvAJ3FDZfY130_assertion description "[First, a Finnish study observed that the NAT2 slow acetylator phenotype was associated with an increased risk of MM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP944547.RAdXHuX-_WmL8a3QdgzLEsOLX8wtw4D4NoGsvAJ3FDZfY130_provenance.
- NP217760.RAyaUceQzTbr3ApWiI6SFZm-P-hwmLiUkHGJkcV-76QWk130_assertion description "[First, a Finnish study observed that the NAT2 slow acetylator phenotype was associated with an increased risk of MM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP217760.RAyaUceQzTbr3ApWiI6SFZm-P-hwmLiUkHGJkcV-76QWk130_provenance.
- NP696751.RAJKGL4JwWD23rRK_C66gBx0OzXsspVG_lpFJxRFfiL2Y130_assertion description "[First, a Finnish study observed that the NAT2 slow acetylator phenotype was associated with an increased risk of MM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP696751.RAJKGL4JwWD23rRK_C66gBx0OzXsspVG_lpFJxRFfiL2Y130_provenance.
- NP696754.RAOUe1lMNjisZj7hsfvXkAMEU0OLgIldho07vAFKZimVE130_assertion description "[First, a Finnish study observed that the NAT2 slow acetylator phenotype was associated with an increased risk of MM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP696754.RAOUe1lMNjisZj7hsfvXkAMEU0OLgIldho07vAFKZimVE130_provenance.
- NP951354.RAJKsSF5g1Yuu0PtJEbJUrnrJVinEuLIWCVw0GrUzt2Fg130_assertion description "[First, a Finnish study observed that the NAT2 slow acetylator phenotype was associated with an increased risk of MM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP951354.RAJKsSF5g1Yuu0PtJEbJUrnrJVinEuLIWCVw0GrUzt2Fg130_provenance.
- NP696749.RA7n0NOSoYrarWBONtSZIzqAZR0WiUW35vvaGTE7qycLI130_assertion description "[First, a Finnish study observed that the NAT2 slow acetylator phenotype was associated with an increased risk of MM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP696749.RA7n0NOSoYrarWBONtSZIzqAZR0WiUW35vvaGTE7qycLI130_provenance.